» Articles » PMID: 24117173

Two-stage Hierarchical Group Testing for Multiple Infections with Application to the Infertility Prevention Project

Overview
Journal Biometrics
Specialty Public Health
Date 2013 Oct 15
PMID 24117173
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Screening for sexually transmitted diseases (STDs) has benefited greatly from the use of group testing (pooled testing) to lower costs. With the development of assays that detect multiple infections, screening practices now involve testing pools of individuals for multiple infections simultaneously. Building on the research for single infection group testing procedures, we examine the performance of group testing for multiple infections. Our work is motivated by chlamydia and gonorrhea testing for the infertility prevention project (IPP), a national program in the United States. We consider a two-stage pooling algorithm currently used to perform testing for the IPP. We first derive the operating characteristics of this algorithm for classification purposes (e.g., expected number of tests, misclassification probabilities, etc.) and identify pool sizes that minimize the expected number of tests. We then develop an expectation-maximization (EM) algorithm to estimate probabilities of infection using both group and individual retest responses. Our research shows that group testing can offer large cost savings when classifying individuals for multiple infections and can provide prevalence estimates that are actually more efficient than those from individual testing.

Citing Articles

Regression analysis of group-tested current status data.

Li S, Hu T, Wang L, McMahan C, Tebbs J Biometrika. 2024; 111(3):1047-1061.

PMID: 39691693 PMC: 11648127. DOI: 10.1093/biomet/asae006.


Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group-Tested Data.

Yang J, Zhang W, Albert P, Liu A, Chen Z Stat Med. 2024; 43(27):5182-5192.

PMID: 39375883 PMC: 11583953. DOI: 10.1002/sim.10230.


Bias Correction in Estimating Proportions by Imperfect Pooled Testing.

Hepworth G, Biggerstaff B J Agric Biol Environ Stat. 2024; 26:90-104.

PMID: 38618153 PMC: 11010583. DOI: 10.1007/s13253-020-00411-5.


Estimating the prevalence of two or more diseases using outcomes from multiplex group testing.

Warasi M, Tebbs J, McMahan C, Bilder C Biom J. 2023; 65(7):e2200270.

PMID: 37192524 PMC: 11099910. DOI: 10.1002/bimj.202200270.


Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies.

Verdun C, Fuchs T, Harar P, Elbrachter D, Fischer D, Berner J Front Public Health. 2021; 9:583377.

PMID: 34490172 PMC: 8416485. DOI: 10.3389/fpubh.2021.583377.


References
1.
Lindan C, Mathur M, Kumta S, Jerajani H, Gogate A, Schachter J . Utility of pooled urine specimens for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in men attending public sexually transmitted infection clinics in Mumbai, India, by PCR. J Clin Microbiol. 2005; 43(4):1674-7. PMC: 1081387. DOI: 10.1128/JCM.43.4.1674-1677.2005. View

2.
Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H . High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods. 2003; 112(1-2):145-51. DOI: 10.1016/s0166-0934(03)00215-5. View

3.
Xie M . Regression analysis of group testing samples. Stat Med. 2001; 20(13):1957-69. DOI: 10.1002/sim.817. View

4.
Bilder C, Tebbs J, Chen P . Informative Retesting. J Am Stat Assoc. 2010; 105(491):942-955. PMC: 2992444. DOI: 10.1198/jasa.2010.ap09231. View

5.
Liu A, Liu C, Zhang Z, Albert P . Optimality of group testing in the presence of misclassification. Biometrika. 2012; 99(1):245-251. PMC: 3412609. DOI: 10.1093/biomet/asr064. View